Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Rabies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Large-scale testing (Phase 3)Study completedNCT07357545
What this trial is testing

Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried

Who this might be right for
Rabies (Healthy Volunteers)
Sinovac Biotech Co., Ltd 2,040
Testing effectiveness (Phase 2)Study completedNCT02956746
What this trial is testing

A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines

Who this might be right for
Human Rabies
Synermore Biologics Co., Ltd. 164
Early research (Phase 1)Study completedNCT06132789
What this trial is testing

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years

Who this might be right for
Rabies
Ab&B Bio-tech Co., Ltd.JS 80
Not applicableLooking for participantsNCT07120464
What this trial is testing

Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

Who this might be right for
Rabies ExposureImmunocompromisedChronic Disease
Liaoning Chengda Biotechnology CO., LTD 180
Early research (Phase 1)Study completedNCT04062669
What this trial is testing

Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 160
Testing effectiveness (Phase 2)Study completedNCT03961555
What this trial is testing

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Who this might be right for
Rabies
Synermore Biologics Co., Ltd. 448